CCSG Supplement: Strengthen the Research, Training, and Outreach Capacity
CCSG 补充:加强研究、培训和推广能力
基本信息
- 批准号:10891139
- 负责人:
- 金额:$ 20万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-08-28 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:Administrative SupplementAdvanced DevelopmentAffectAgeCancer BurdenCancer CenterCancer Center Support GrantCancer PatientEducationEducational workshopEmployeeFundingFunding OpportunitiesGoalsGrantMalignant NeoplasmsMinorityMissionMorbidity - disease rateOutcomePatient CarePersonsPopulationPostdoctoral FellowPreventionPrincipal InvestigatorResearchResearch PersonnelResourcesScienceTexasTrainingTraining ProgramsTraining SupportUnderrepresented MinorityUniversity of Texas M D Anderson Cancer CenterVisioncancer health disparitycareer developmenteconomic disparityexperiencegraduate studentimprovedmortalityoutreachpre-doctoralprogramssymposiumtraining opportunityundergraduate educationundergraduate student
项目摘要
P30 Administrative Supplement to The University of Texas MD Anderson Cancer Center’s “Cancer
Center Support Grant” (P30 CA016672 47, Principal Investigator: Peter T. Pisters, MD)
PROJECT SUMMARY: This supplement proposes the implementation of a collaborative training program to
connect underrepresented minority scholars with training navigators. Training navigators will help connect
scholars to the Continuing Umbrella of Research Experiences (CURE) program. Our goals for this supplement
funding period are to fund scholars’ career development activities, workshops, conferences, and certificates.
Combining the rich resources of MD Anderson, the aims of this supplement are to: 1) Identify
underrepresented minority scholars (predoctoral, postdoctoral fellows, or early-stage investigators); 2) Engage
and provide training support to scholars; and 3) Leverage two existing TNs with expertise in career
development and grant administration and hire a third TN with expertise in cancer health disparities and
connection to CURE and Region 3 GMaP research, training, and funding opportunities.
RELEVANCE: This supplement proposes the implementation and completion of a Training Navigation
program, which will provide hands-on support to assist predoctoral and postdoctoral fellows and early-stage
investigators with their educational advancement and career development activities.
P30德克萨斯大学MD安德森癌症中心“癌症”的行政补充
中心支持赠款”(P30 CA 016672 47,主要研究者:彼得T。Pisters,MD)
项目摘要:本补充建议实施合作培训计划,
将代表性不足的少数民族学者与培训导航员联系起来。训练导航员将有助于连接
研究经验的持续伞(CURE)计划。我们的目标是这个补充
资助期内的主要用途是资助学者的职业发展活动、工作坊、会议及颁发证书。
结合MD安德森的丰富资源,本增刊的目的是:1)识别
代表性不足的少数民族学者(博士前,博士后研究员或早期研究人员); 2)参与
并为学者提供培训支持;以及3)利用现有的两个具有职业专业知识的TN
发展和赠款管理,并聘请第三个TN与癌症健康差距的专业知识,
与CURE和第3区GMaP的研究、培训和资助机会建立联系。
相关性:本补充建议实施和完成培训导航
计划,这将提供动手支持,以协助博士前和博士后研究员和早期阶段
调查人员的教育进步和职业发展活动。
项目成果
期刊论文数量(1123)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI.
- DOI:10.1038/s41598-023-27518-2
- 发表时间:2023-01-20
- 期刊:
- 影响因子:4.6
- 作者:
- 通讯作者:
Mid-treatment Ultrasound Descriptors as Qualitative Imaging Biomarkers of Pathologic Complete Response in Patients with Triple-Negative Breast Cancer.
- DOI:10.1016/j.ultrasmedbio.2022.01.018
- 发表时间:2022-06
- 期刊:
- 影响因子:2.9
- 作者:Candelaria, Rosalind P.;Adrada, Beatriz E.;Lane, Deanna L.;Rauch, Gaiane M.;Moulder, Stacy L.;Thompson, Alastair M.;Bassett, Roland L.;Arribas, Elsa M.;Le-Petross, Huong T.;Leung, Jessica W. T.;Spak, David A.;Ravenberg, Elizabeth E.;White, Jason B.;Valero, Vicente;Yang, Wei T.
- 通讯作者:Yang, Wei T.
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651.
- DOI:10.1200/jco.22.00332
- 发表时间:2023-04-20
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome.
- DOI:10.1016/j.surg.2022.03.014
- 发表时间:2022-08
- 期刊:
- 影响因子:3.8
- 作者:Landry, Jace P.;Clemente-Gutierrez, Uriel;Pieterman, Carolina R. C.;Chiang, Yi-Ju;Waguespack, Steven G.;Jimenez, Camilo;Habra, Mouhammed A.;Halperin, Daniel M.;Fisher, Sarah B.;Graham, Paul H.;Perrier, Nancy D.
- 通讯作者:Perrier, Nancy D.
Bismuth Nanoparticle and Polyhydroxybutyrate Coatings Enhance the Radiopacity of Absorbable Inferior Vena Cava Filters for Fluoroscopy-Guided Placement and Longitudinal Computed Tomography Monitoring in Pigs.
- DOI:10.1021/acsbiomaterials.1c01449
- 发表时间:2022-04-11
- 期刊:
- 影响因子:5.8
- 作者:Damasco, Jossana A.;Huang, Steven Y.;Perez, Joy Vanessa D.;Manongdo, John Andrew T.;Dixon, Katherine A.;Williams, Malea L.;Jacobsen, Megan C.;Barbosa, Roland;Canlas, Gino Martin;Chintalapani, Gouthami;Melancon, Adam D.;Layman, Rick R.;Fowlkes, Natalie W.;Whitley, Elizabeth M.;Melancon, Marites P.
- 通讯作者:Melancon, Marites P.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Giulio Francesco Draetta其他文献
Giulio Francesco Draetta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Giulio Francesco Draetta', 18)}}的其他基金
Project 5: Targeting Oxidative Phosphorylation in AML
项目 5:针对 AML 中的氧化磷酸化
- 批准号:
10931070 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Medium-chain acyl-coenzyme A dehydrogenase as an essential feeder of glioblastoma multiforme
中链酰基辅酶 A 脱氢酶作为多形性胶质母细胞瘤的重要饲养者
- 批准号:
10094200 - 财政年份:2018
- 资助金额:
$ 20万 - 项目类别:
Medium-chain acyl-coenzyme A dehydrogenase as an essential feeder of glioblastoma multiforme
中链酰基辅酶 A 脱氢酶作为多形性胶质母细胞瘤的重要饲养者
- 批准号:
10335175 - 财政年份:2018
- 资助金额:
$ 20万 - 项目类别:
Project 5: Targeting Oxidative Phosphorylation in AML
项目 5:针对 AML 中的氧化磷酸化
- 批准号:
10006817 - 财政年份:2003
- 资助金额:
$ 20万 - 项目类别:
Project 5: Targeting Oxidative Phosphorylation in AML
项目 5:针对 AML 中的氧化磷酸化
- 批准号:
10247507 - 财政年份:2003
- 资助金额:
$ 20万 - 项目类别:
CCSG Supplement: Early-stage Surgeon Scientist Program (ESSP) - Chibawanye Ene
CCSG 增刊:早期外科医生科学家计划 (ESSP) - Chibawanye Ene
- 批准号:
10748481 - 财政年份:1996
- 资助金额:
$ 20万 - 项目类别:
Project 5: Targeting Oxidative Phosphorylation in AML
项目 5:针对 AML 中的氧化磷酸化
- 批准号:
9762859 - 财政年份:
- 资助金额:
$ 20万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 20万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 20万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 20万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 20万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 20万 - 项目类别:














{{item.name}}会员




